BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28545023)

  • 21. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Kong Q; Qiu M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXA cluster antisense RNA 2 elevates KIAA1522 expression through microRNA-520d-3p and insulin like growth factor 2 mRNA binding protein 3 to promote the growth of vascular smooth muscle cells in thoracic aortic aneurysm.
    Ou M; Chu Y; Zhang Q; Zhao H; Song Q
    ESC Heart Fail; 2022 Oct; 9(5):2955-2966. PubMed ID: 35730141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of lncRNA HOXA-AS2 Inhibits Viability, Migration and Invasion of Osteosarcoma Cells by miR-124-3p/E2F3.
    Wang L; Wang L; Zhang X
    Onco Targets Ther; 2019; 12():10851-10861. PubMed ID: 31853184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.
    Shi YB; Liu SL; Mou XR; Liao J; Che JP; Fei XQ; Wang AR
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1243-1249. PubMed ID: 32096154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
    Feng Y; Hu S; Li L; Peng X; Chen F
    Cell Death Dis; 2020 Dec; 11(12):1025. PubMed ID: 33268767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B.
    Yang Z; Zhang F; Cai K; Xu J
    Kidney Blood Press Res; 2023; 48(1):45-55. PubMed ID: 36404720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOXA-AS2 accelerates the proliferation and migration and inhibits the apoptosis of vascular smooth muscle cells by absorbing miRNA-877-3p.
    Fan TT; Liu YX; Wang XC; Xu BL; Chen ZC; Lu HA; Zhang M
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):362-368. PubMed ID: 31957850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HOXA-AS2 Promotes Temozolomide Resistance in Glioblastoma by Regulated miR-302a-3p/IGF1 Axis.
    Lin L; Lin D; Jin L; Wang J; Lin Z; Zhang S; Lin G
    Genet Res (Camb); 2022; 2022():3941952. PubMed ID: 36479381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.
    Li W; Jin X; Zhao Y; Dai J; Cai Y
    Pathol Res Pract; 2020 Feb; 216(2):152772. PubMed ID: 31839366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.
    Li ZK; Gao LF; Zhu XA; Xiang DK
    Biochem Genet; 2021 Oct; 59(5):1158-1172. PubMed ID: 33687636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
    Yang JX; Liu B; Yang BY; Meng Q
    Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-Coding RNA LPP-AS2 Plays an Anti-Tumor Role in Thyroid Carcinoma by Regulating the miR-132-3p/OLFM1 Axis.
    Zhang B; Liu T; Gu Y; Ren L; Wang J; Feng C; Song Z
    Crit Rev Eukaryot Gene Expr; 2023; 33(5):73-86. PubMed ID: 37199315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p.
    Yang Y; Xun N; Wu JG
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6971-6982. PubMed ID: 31486497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.